Dr. Xu came to Maimonides from the National Cancer Institute designated Arthur James Cancer Center at Ohio State. At Ohio State, she specialized in the research and management of gastrointestinal cancers and both designed and participated in national research trials of new therapies for these cancers.
Dr. Xu holds a PhD in tumor immunology from Cornell University Medical Center, and has done research at Memorial Sloan Kettering Medical Center with a focus in Melanoma immunotherapy. She also has completed a fellowship training in medical oncology at the Robert Wood Johnson Medical Center in New Jersey and at the Ohio State Cancer Center.
Dr. Xu’s clinical practice and research interests are focused on the treatment of cancers of the gastrointestinal tract, gynecological cancers, lung and breast cancers and other solid malignancies. She has special interests in translational research, particularly in the fields of the Vascular Endothelium Growth Factor (VEGF) signaling pathway in cancer and hematological diseases and in Hereditary Colon Cancer syndrome in Asian patients.
She is a recipient of a grant from the Maimonides Research Foundation to further her research.